Drug-induced or toxic liver disease with fatty liver

Description

This is a drug-induced fatty liver that consists of three types of steatosis, including microvesicular steatosis, macrovesicular steatosis, and phospholipidosis.

Exclusions from above levels

DB94 – Alcoholic liver disease
DB98.5 – Budd-Chiari syndrome
ME10.1 – Unspecified jaundice

Show allHide

01 – Certain infectious or parasitic diseases
02 – Neoplasms
05 – Endocrine, nutritional or metabolic diseases
06 – Mental, behavioural or neurodevelopmental disorders
18 – Complications of pregnancy, childbirth and the puerperium
22 – Injury, poisoning or certain other consequences of external causes

Child codes

DB95.30 – Drug-induced or toxic liver disease with chronic fatty liver disease
DB95.3Y – Other specified drug-induced or toxic liver disease with fatty liver
DB95.3Z – Drug-induced or toxic liver disease with fatty liver, unspecified

Sibling codes

DB95.0 – Drug-induced or toxic liver disease with acute hepatic necrosis or acute hepatitis
DB95.1 – Drug-induced or toxic liver disease with chronic hepatitis
DB95.2 – Drug-induced or toxic liver disease with cholestasis
DB95.4 – Drug-induced or toxic liver disease with granulomatous hepatitis
DB95.5 – Drug-induced or toxic liver disease with fibrosis or cirrhosis of liver
DB95.6 – Drug-induced or toxic liver disease with vascular disorders of the liver
DB95.7 – Drug-induced or toxic liver disease with liver tumours
DB95.Y – Other specified drug-induced or toxic liver disease
DB95.Z – Drug-induced or toxic liver disease, unspecified

Foundation entity

Drug-induced or toxic liver disease with fatty liver – http://id.who.int/icd/entity/1338213145

Allowed postcoordination axes

Part of: DB95: Drug-induced or toxic liver disease › 13: Diseases of the digestive system